sur Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health Schedules Investor Webcast for Q1 2025 Financials
Jaguar Health, Inc. (NASDAQ: JAGX) has announced an investor webcast scheduled for May 15, 2025, at 4:15 PM Eastern Time. This event will focus on the company's first-quarter 2025 financial results and recent corporate updates. The webcast provides an opportunity for stakeholders to understand Jaguar Health's performance and future trajectory.
The company plans to publish its earnings report on Form 10-Q on the same day, covering the quarter that ended on March 31, 2025. Interested participants are encouraged to register through the provided link.
Jaguar Health, a commercial-stage pharmaceuticals company, specializes in developing proprietary medicines from plants. Their scope includes treatments for human and animal gastrointestinal issues, with a notable focus on overactive bowel conditions.
Subsidiary Napo Pharmaceuticals focuses on human prescription drugs, while Napo Therapeutics aims to expand access to crofelemer in Europe. Additionally, Jaguar's joint venture, Magdalena Biosciences, targets novel treatments for mental health.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Jaguar Health, Inc.